MEDICAL CHANNEL ASIA

PUBLIC PORTAL

PUBLIC PORTAL

MEDICALLY REVIEWED

HSA Approves New JAK inhibitor Abrocitinib (Cibinqo) For The Treatment of Atopic Dermatitis

abrocitinib

The disease burden and current treatment landscape
Atopic dermatitis (AD), or eczema, is the most common skin disorder in Singapore and is estimated to affect 20% of children and 11% of adults in Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

Allergy medical center

Understanding and Managing Airborne Allergies

This article provides an overview of different types of allergies in Southeast Asia, including pollen, food, dust mite, insect sting, and mold allergies. It discusses the prevalence of each allergy in different countries, symptoms, and management options. The article aims to help readers understand and manage their allergies for a better quality of life.

Read More »

People also read: